Hap Trading, LLC Agenus Inc Call Options Transaction History

Hap Trading, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $24,644 - $39,650	-12,200 Reduced 7.93%	141,600 $7,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $102,704 - $164,536	52,400 Added 51.68%	153,800 $14,000
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.64 $31,070 - $63,096	-23,900 Reduced 19.07%	101,400 $13,000
Q1 2022 May 12, 2022	BUY	$2.35 - $3.47 $220,430 - $325,486	93,800 Added 297.78%	125,300 $18,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $4,672 - $9,184	-1,600 Reduced 4.83%	31,500 $9,000
Q3 2021 Nov 10, 2021	BUY	$4.98 - $6.63 $69,720 - $92,820	14,000 Added 73.3%	33,100 $18,000
Q2 2021 Aug 11, 2021	SELL	$2.56 - $5.49 $56,320 - $120,780	-22,000 Reduced 53.53%	19,100 $22,000
Q1 2021 May 14, 2021	BUY	$2.69 - $5.25 $46,806 - $91,350	17,400 Added 73.42%	41,100 $10,000
Q4 2020 Feb 16, 2021	SELL	$3.17 - $4.49 $7,925 - $11,225	-2,500 Reduced 9.54%	23,700 $6,000
Q3 2020 Nov 13, 2020	BUY	$2.98 - $5.2 $44,700 - $78,000	15,000 Added 133.93%	26,200 $10,000
Q2 2020 Aug 10, 2020	SELL	$2.29 - $4.24 $27,938 - $51,728	-12,200 Reduced 52.14%	11,200 $11,000
Q1 2020 May 08, 2020	BUY	$1.92 - $4.39 $18,816 - $43,022	9,800 Added 72.06%	23,400 $5,000
Q4 2019 Feb 11, 2020	BUY	$2.41 - $4.4 $32,776 - $59,840	13,600 New	13,600 $8,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.